Biofrontera AG | CIK:0001712641 | 3

  • Filed: 4/30/2018
  • Entity registrant name: Biofrontera AG (CIK: 0001712641)
  • Generator: Novaworks Software
  • SEC filing page: http://www.sec.gov/Archives/edgar/data/1712641/000149315218005915/0001493152-18-005915-index.htm
  • XBRL Instance: http://www.sec.gov/Archives/edgar/data/1712641/000149315218005915/bfra-20171231.xml
  • XBRL Cloud Viewer: Click to open XBRL Cloud Viewer
  • EDGAR Dashboard: https://edgardashboard.xbrlcloud.com/edgar-dashboard/?cik=0001712641
  • Open this page in separate window: Click
  • ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory

    Application of estimates

     

    The preparation of the consolidated financial statements for 31 December 2017 in accordance with IFRS required the use of estimates and assumptions by the management that affect the value of assets and liabilities as reported on the balance sheet date, and revenues and expenses arising during the financial year. The main areas in which assumptions, estimates and the exercising of a degree of discretion are appropriate relate to the determination of the useful lives of non-current assets and the formation of provisions, as well as income taxes. Estimates are also made as part of fair value measurement pursuant to IFRS 13. Estimates are based on historical experience and other assumptions that are considered appropriate in the circumstances. They are continuously reviewed but may vary from the actual values.

     

    The carrying amounts of items affected by estimates are presented in the respective explanatory remarks concerning the items in the notes to the consolidated financial statements.